Ameritas Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Ameritas Investment Partners’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$173K	Hold	12,485	–	–	0.01%	1349
2025 Q4	$203K	Hold	12,485	–	–	0.01%	1247
2025 Q3	$187K	Sell	12,485 -2,773	-18%	-$33.8K	0.01%	1280
2025 Q2	$178K	Buy	15,258 +3,972	+35%	+$36.1K	0.01%	1370
2025 Q1	$83.9K	Hold	11,286	–	–	﹤0.01%	1820
2024 Q4	$67.7K	Hold	11,286	–	–	﹤0.01%	2007
2024 Q3	$57.8K	Hold	11,286	–	–	﹤0.01%	2103
2024 Q2	$40.9K	Hold	11,286	–	–	﹤0.01%	2248
2024 Q1	$36.2K	Hold	11,286	–	–	﹤0.01%	2305
2023 Q4	$55.3K	Hold	11,286	–	–	﹤0.01%	2117
2023 Q3	$61.5K	Buy	11,286 +2,924	+35%	+$19.3K	﹤0.01%	1971
2023 Q2	$56.1K	Hold	8,362	–	–	﹤0.01%	1977
2023 Q1	$73.8K	Hold	8,362	–	–	﹤0.01%	1732
2022 Q4	$78.6K	Hold	8,362	–	–	﹤0.01%	1759
2022 Q3	$59K	Hold	8,362	–	–	﹤0.01%	1854
2022 Q2	$67K	Buy	+8,362	New	+$73.5K	﹤0.01%	1787

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameritas Investment Partners's ADPT Position: Q1 2026 in Review

Ameritas Investment Partners held its Adaptive Biotechnologies (ADPT) position steady in Q1 2026 at 12,485 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #1349.

Ameritas Investment Partners first reported a position in ADPT in Q2 2022 and has held it in 16 quarters since. The position peaked at $203K in Q4 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

Ameritas Investment Partners held 12,485 shares of Adaptive Biotechnologies worth $173K as of Q1 2026.
Ameritas Investment Partners left its Adaptive Biotechnologies share count unchanged in Q1 2026.
Adaptive Biotechnologies made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1349 holding.
Ameritas Investment Partners first reported a position in Adaptive Biotechnologies in Q2 2022 and has held it in 16 quarters since.
Ameritas Investment Partners's Adaptive Biotechnologies position peaked at $203K in Q4 2025.
295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.